Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
119-hr-5160119th CongressWALLET
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Sponsored By: Representative Smith, Christopher H. [R-NJ-4]
Passed House
Summary
Reauthorizes stem cell funding and modernizes cord blood inventory management. The bill sets specific funding for a key transplantation program and gives the Secretary authority to run the National Cord Blood Inventory using current science and clinical standards.
Show full summary
- Patients and families: More reliable access to high-quality cord blood for transplants because inventory rules now prioritize clinical utility and genetic diversity to improve matches.
- Cord blood banks and collections: The fixed target of 150,000 new units is replaced by a flexible threshold set by the Secretary. Banks must meet current industry and Food and Drug Administration standards and the Secretary can transfer units if a bank becomes non-operational.
- Programs and researchers: The C.W. Young Cell Transplantation Program gets $31.0 million initially and $33.0 million per year for fiscal years 2027 through 2031, giving steady funding for transplants and research support.
*This law increases federal spending by about $31.0 million upfront and $33.0 million per year through 2031 for these programs.*
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Better cord blood access for patients
The bill would replace the 150,000‑unit target with a flexible supply set by HHS. The Secretary would manage the national inventory to match clinical needs and genetic diversity using current science. The Secretary would decide which units to collect, keep, or remove when they no longer meet standards. "High‑quality" would mean units that meet current industry and FDA standards. If a bank shuts down or fails rules, HHS would move units to another approved bank so patients can still get them.
Funding for stem cell transplants through 2031
The bill would set authorized funding for the C.W. Bill Young Cell Transplantation Program. It would authorize $31.009 million, and $33.009 million each year from 2027 through 2031. It would also extend the National Cord Blood Inventory’s authorization to fiscal years 2027–2031. Congress would still need to approve yearly spending.
Sponsors & CoSponsors
Sponsor
Smith, Christopher H. [R-NJ-4]
NJ • R
Cosponsors
Rep. Matsui, Doris O. [D-CA-7]
CA • D
Sponsored 9/4/2025
Rep. Bilirakis, Gus M. [R-FL-12]
FL • R
Sponsored 9/4/2025
Rep. Pingree, Chellie [D-ME-1]
ME • D
Sponsored 9/4/2025
Rep. Tenney, Claudia [R-NY-24]
NY • R
Sponsored 9/4/2025
Rep. Mfume, Kweisi [D-MD-7]
MD • D
Sponsored 9/4/2025
Rep. Fischbach, Michelle [R-MN-7]
MN • R
Sponsored 2/4/2026
Rep. Dingell, Debbie [D-MI-6]
MI • D
Sponsored 2/4/2026
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 2/10/2026
Rep. Aderholt, Robert B. [R-AL-4]
AL • R
Sponsored 2/10/2026
Rep. Castor, Kathy [D-FL-14]
FL • D
Sponsored 4/2/2026
Rep. Malliotakis, Nicole [R-NY-11]
NY • R
Sponsored 4/2/2026
Rep. Garbarino, Andrew R. [R-NY-2]
NY • R
Sponsored 4/2/2026
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 4/2/2026
Rep. Bentz, Cliff [R-OR-2]
OR • R
Sponsored 4/27/2026
Rep. Barragán, Nanette Diaz [D-CA-44]
CA • D
Sponsored 4/27/2026
Rep. Finstad, Brad [R-MN-1]
MN • R
Sponsored 4/30/2026
Rep. Morrison, Kelly [D-MN-3]
MN • D
Sponsored 4/30/2026
Rep. Lawler, Michael [R-NY-17]
NY • R
Sponsored 5/21/2026
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 5/21/2026
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 5/29/2026
Rep. Davids, Sharice [D-KS-3]
KS • D
Sponsored 5/29/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov